Intended for healthcare professionals

  1. Education
  2. Management of...
  3. Management of rheumatoid arthritis: summary of NICE guidance
Practice Guidelines

Management of rheumatoid arthritis: summary of NICE guidance

BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b702 (Published 16 March 2009) Cite this as: BMJ 2009;338:b702

Related articles

  • No related articles found.

See more

Cited by...

  • Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study
  • Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance
  • Hand exercises for patients with rheumatoid arthritis: an extended follow-up of the SARAH randomised controlled trial
  • Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial
  • Efficacy of etanercept in combination with methotrexate in moderate-to-severe rheumatoid arthritis is not dependent on methotrexate dosage
  • Do Genetic Susceptibility Variants Associate with Disease Severity in Early Active Rheumatoid Arthritis?
  • Pattern of drugs use and association with anti-mutated citrullinated vimentin antibody in rheumatoid arthritis
  • Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial
  • Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial
  • The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial
  • Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial
  • Aerobic exercise is beneficial for people with rheumatoid arthritis
  • The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept
  • Canadian Recommendations for Use of Methotrexate in Patients with Rheumatoid Arthritis
  • Delayed Addition of Glucocorticoids Selectively Suppresses Cytokine Production in Stimulated Human Whole Blood
  • How does rheumatoid arthritis need to be managed?
Back to top